IRADIMED Q4 revenue $19.4M (+11% YoY); raises quarterly dividend to $0.17/share

IRADIMED CORP

2024-FY EPS reported $1.50 revenue$73,242,121

Q4 revenue record $19.4M (+11% YoY); GAAP EPS $0.40, non-GAAP EPS $0.44.
Full year 2024 revenue $73.2M (+12% YoY); GAAP EPS $1.50, non-GAAP EPS $1.66.
Quarterly dividend increased 13% to $0.17/share from $0.15; payable March 5, 2025.
FY2025 guidance: revenue $78-82M, GAAP EPS $1.55-1.65, non-GAAP EPS $1.71-1.81.
New Orlando facility on track for mid-2025 completion; ~$5.5M capex remaining in 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.